Skip to main content

Table 3 Baseline data, pyrogenic factors and use of antibiotics and thrombolysis

From: Temporal profile of body temperature in acute ischemic stroke: relation to stroke severity and outcome

  

Total n=44

No pyrexia n=28

Pyrexia n=16

 

Sex

     
 

Male

21

15

6

 
 

Female

23

13

10

 

Mean Age in years, (SD)

 

71.9 (11.4)

71.9 (11.7)

71.9 (11.3)

p=0.990

Stroke Subtype

     
 

TACS

14

5

9

TACS vs

 

PACS

19

14

5

non-TACS

 

LACS

6

6

0

χ2=6.9

 

POCS

5

3

2

p=0.009

Stroke severity

     
 

Median NIHSS (IQR)

7 (3–14)

6.5 (3–10)

12 (5–18)

p=0.0381 (MWU)

Temperature

     
 

Time to peak, median hours after stroke, (IQR)

35.5 (19–53.8)

36.0 (7.8-59.3)

32.5 (22.8-51.3)

p=0.652 (MWU)

N o . with ≥1 pyrogenic factor identified*

 

16 (36%)

7 (25%)

9 (56%)

 
 

Urinary catheter

8

3

5

 
 

NG tube

9

4

5

 
 

Surgical procedure

4

2

2

 
 

DVT

0

0

0

 
 

Infection: urinary

2

0

2

 
 

Infection: respiratory

7

4

3

 

Antibiotics

 

10

4 (14%)

6 (38%)

 

Paracetamol

 

13

7 (25%)

6 (38%)

 

Thrombolysis

 

3

1 (4%)

2 (13%)

 

90 day mRS

     
 

mRS ≤2

19

15

4

χ2=3.5

 

mRS ≥3

25

13

12

p=0.061

  1. *Some patients had more than 1 potential cause of pyrexia. Pyrexia was defined as tympanic temperature ≥37.5°C. SD: standard deviation; TACS: total anterior circulation stroke; PACS: partial anterior circulation stroke; LACS: lacunar stroke; POCS: posterior circulation stroke; NIHSS: National Institute of Health Stroke Score; IQR: interquartile range; MWU: Mann Whitney U test; NG: nasogastric; DVT: deep venous thrombosis; mRS: modified Rankin Score.